Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant

As nucleocapsid protein of severe acute respiratory syndrome coronavirus 2 is immunogenic but not targeted in vaccines, it could be useful in distinguishing natural infection from vaccination. We aimed to investigate the clinical utility of sero-immunological responses against the nucleocapsid prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Beomki, Ko, Jae-Hoon, Baek, Jin Yang, Kim, Haein, Huh, Kyungmin, Cho, Sun Young, Kang, Cheol-In, Chung, Doo Ryeon, Peck, Kyong Ran, Kang, Eun-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506902/
https://www.ncbi.nlm.nih.gov/pubmed/37724496
http://dx.doi.org/10.3346/jkms.2023.38.e292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506902/
https://www.ncbi.nlm.nih.gov/pubmed/37724496
http://dx.doi.org/10.3346/jkms.2023.38.e292

Ejemplares similares